These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma. Boué F, Gabarre J, Gisselbrecht C, Reynes J, Cheret A, Bonnet F, Billaud E, Raphael M, Lancar R, Costagliola D. J Clin Oncol; 2006 Sep 01; 24(25):4123-8. PubMed ID: 16896005 [Abstract] [Full Text] [Related]
6. [Malignant lymphoma associated with HIV infection]. Mitrou PS, Serke M, Pohl C, Becker K, Schrappe-Bächer M, Knauf W, Westerhausen M, Clemens MR, Helm EB, Fischer T. Dtsch Med Wochenschr; 1991 Aug 16; 116(33):1217-23. PubMed ID: 1874122 [Abstract] [Full Text] [Related]
7. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group. Sieber M, Bredenfeld H, Josting A, Reineke T, Rueffer U, Koch T, Naumann R, Boissevain F, Koch P, Worst P, Soekler M, Eich H, Müller-Hermelink HK, Franklin J, Paulus U, Wolf J, Engert A, Diehl V, German Hodgkin's Lymphoma Study Group. J Clin Oncol; 2003 May 01; 21(9):1734-9. PubMed ID: 12721249 [Abstract] [Full Text] [Related]
9. The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy. Navarro JT, Lloveras N, Ribera JM, Oriol A, Mate JL, Feliu E. Haematologica; 2005 May 01; 90(5):704-6. PubMed ID: 15921395 [Abstract] [Full Text] [Related]
11. [Primary hepatic non-Hodgkin's lymphoma]. De la Maya MD, Escalante R, Torre A, Urdambidelus C. Sangre (Barc); 1999 Jun 01; 44(3):242. PubMed ID: 10481592 [No Abstract] [Full Text] [Related]
12. Human immunodeficiency virus-associated diffuse non-Hodgkin's lymphoma in Venezuelan patients: treatment with full-dose cyclophosphamide-doxorubicin-vincristine-prednisone without routine use of granulocyte-colony stimulating factor. Hernàndez DE, Hernàndez AE. Eur J Cancer Care (Engl); 2006 Dec 01; 15(5):493-6. PubMed ID: 17177909 [Abstract] [Full Text] [Related]
13. Intensive sequential chemotherapy with hematopoietic growth factor support for non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus. Costello RT, Zerazhi H, Charbonnier A, de Colella JM, Alzieu C, Poizot-Martin I, Cohen R, Bardou VJ, Xerri L, Olive D, Nezri M, Lepeu G, Gastaut JA. Cancer; 2004 Feb 15; 100(4):667-76. PubMed ID: 14770420 [Abstract] [Full Text] [Related]
14. Non-Hodgkin's lymphoma (diffuse large B cell lymphoma). Copson E. Clin Evid; 2005 Jun 15; (13):1-18. PubMed ID: 16135258 [No Abstract] [Full Text] [Related]
18. Lactic Acidosis in Non-Hodgkin's Lymphoma and response to Chemotherapy. Osorio S, Bernis C, de La Cámara R. Haematologica; 2002 Feb 15; 87(2):ELT05. PubMed ID: 11836182 [No Abstract] [Full Text] [Related]
19. Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study. Simonelli C, Spina M, Cinelli R, Talamini R, Tedeschi R, Gloghini A, Vaccher E, Carbone A, Tirelli U. J Clin Oncol; 2003 Nov 01; 21(21):3948-54. PubMed ID: 14581418 [Abstract] [Full Text] [Related]
20. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone). Voulgarelis M, Giannouli S, Tzioufas AG, Moutsopoulos HM. Ann Rheum Dis; 2006 Aug 01; 65(8):1033-7. PubMed ID: 16322082 [Abstract] [Full Text] [Related] Page: [Next] [New Search]